ETN vs STRO · P/E 39, rev $27.45B vs rev $62.0M
Eaton Corporation PLC (ETN) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Eaton Corporation PLC (ETN) is a specialty industrial machinery company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported ETN revenue for 2025-12-31 was $27.45B. Net income was $4.09B. Revenue was up 10.3% from 2024-12-31 to 2025-12-31. ETN currently screens at market cap $153.74B and trailing P/E 38.7.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
ETN currently screens at market cap $153.74B and trailing P/E 38.7. STRO currently screens at market cap $470.8M.
Not investment advice. Open the ETN and STRO stock pages for the full models.
Not investment advice.